At the functional natural material development business agreement ceremony, Park Hyung-geun, team leader of Dong-A Pharmaceutical Research Institute (right), and Choi Il, director of BST Research Institute, are posing for a commemorative photo.

At the functional natural material development business agreement ceremony, Park Hyung-geun, team leader of Dong-A Pharmaceutical Research Institute (right), and Choi Il, director of BST Research Institute, are posing for a commemorative photo.

View original image


[Asia Economy Reporter Lee Gwan-ju] Dong-A Pharmaceutical announced on the 27th that it has signed a business agreement with BST for the development of natural raw materials for cosmetics.


This agreement was established to replace imported cosmetic raw materials with domestic native plant raw materials and to secure foundational technologies and basic materials for developing high value-added anti-aging dermocosmetic products by utilizing agricultural products discarded by farms.


Under the agreement, both companies plan to develop cosmetic materials with anti-aging efficacy using clean Jeju green tangerines as raw materials, share the latest research and development information, and promote various activities such as joint development of ESG (Environmental, Social, and Governance) compliant raw materials.


BST, established in 2000, is the first venture company in the cosmetics sector recognized by the Ministry of Health and Welfare, developing raw materials and products using natural substances.


Choi Il, head of BST’s research institute, stated, “Our company has accumulated know-how and technology for developing and commercializing functional materials derived from natural substances, and based on this experience, we will successfully carry out the development of innovative, customized, and safe natural materials for our clients.”



Park Hyung-geun, team leader of Dong-A Pharmaceutical’s research institute, said, “Through this cooperation with BST, we expect to increase the localization rate of cosmetic materials and promote mutual growth with domestic farms and small and medium-sized enterprises. We will continue to practice Dong-A Pharmaceutical’s ESG management by revitalizing the eco-friendly sustainable materials industry.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing